Variable |
MDD-A (n = 25) |
MDD (n = 20) |
HC (n = 23) |
|
|
(p-value) |
|
|
|
|
|
(p-value) |
|
|
|
|
|
Demographic |
|
|
|
|
|
Age, years (s.d.) |
33.3 (10.9) |
39.40 (14.3) |
33.8 (11.7) |
F
(2,65) = 1.64 (.203) |
|
Sex, male, n (%) |
12 (48) |
11 (55) |
13 (56.5) |
χ2
(2, N = 68) = 0.40 (.820) |
|
Pharmacotherapy, yes, n (%) |
16 (64) |
17 (85) |
0 (0) |
|
χ2 (1, N = 45) = 6.05, df = 2 (.042)* |
Duration of illness, months (s.d.) |
72.07 (105.68) |
38.49 (47.83) |
- |
|
Z = -0.37 (.722) |
Clinical scores |
|
|
|
|
|
BDI-II, mean (s.d.) |
25.8 (12.5) |
30.8 (11.5) |
1.00 (1.4) |
F
(2,65) = 58.3 (<.001)*** |
Z = -1.26
(.213) |
BAI, mean (s.d.) |
17.8 (10.9) |
22.1 (13.7) |
3.0 (4.8) |
F
(2,65) = 20.8 (<.001)*** |
Z = -.889
(.381) |